arrow
F

Faguang Jin

the fourth military medical university
H指数:35
被引数:4,477

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 study

通过EGFR突变状态评估安洛替尼作为非小细胞肺癌三线治疗的疗效: ALTER0303随机3期研究的亚组分析

2022-05-017
OAAI
The development of bronchoscopy in China: a national cross-sectional study
2020-01-014
OAAI
The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial

既往治疗策略对盐酸安洛替尼三线治疗晚期非小细胞肺癌 (NSCLC) 疗效的影响: ALTER0303试验的亚组分析

2019-10-0133
OAAI